The aim of the 2nd Brighton Tumour Microenvironment Conference is to showcase cutting‑edge developments in tumour microenvironment (TME) research, with a focus on the mechanisms underpinning TME‑driven tumour progression and therapy resistance. The programme will explore extracellular matrix (ECM) dynamics, immune–TME interactions, the perivascular niche, tumour angiogenesis, and emerging therapeutic targets within the TME.
The 2nd Brighton Tumour Microenvironment Conference places strong emphasis on inclusivity and on supporting Early Career Researchers (ECRs) through dedicated opportunities to present their work at this meeting.